Nature Medicine, Published online: 19 June 2026; doi:10.1038/s41591-026-04519-y Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial